These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7064132)

  • 21. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonist.
    Friedhoff LT; Manning J; Funke PT; Ivashkiv E; Tu J; Cooper W; Willard DA
    Clin Pharmacol Ther; 1986 Dec; 40(6):634-42. PubMed ID: 3780125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The thromboxane mimetic, U-46619, induces the aggregation of fish thrombocytes.
    Hill DJ; Rowley AF
    Br J Haematol; 1996 Jan; 92(1):200-11. PubMed ID: 8562396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-dependent inhibition by glyceryl trinitrate of platelet aggregation caused by U46619 (a thromboxane/endoperoxide receptor agonist).
    Kampf G; Ritter JM
    Br J Clin Pharmacol; 1994 Jul; 38(1):80-2. PubMed ID: 7946941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK; Ullian ME; Halushka PV
    J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
    J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potentiation of phorbol ester-induced aggregation of human platelets by the prostaglandin endoperoxide analogue, U46619.
    Edwards MC; Williamson EM; Evans FJ
    J Pharm Pharmacol; 1987 May; 39(5):370-7. PubMed ID: 2886585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Succinate potentiates the action of platelet agonists.
    Huang EM; McGowan EB; Detwiler TC
    Thromb Res; 1984 Oct; 36(1):1-8. PubMed ID: 6095483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study.
    Barradas MA; Jagroop A; O'Donoghue S; Jeremy JY; Mikhailidis DP
    Thromb Res; 1993 Aug; 71(3):227-36. PubMed ID: 8267765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
    Yun JC; Ohman KP; Gill JR; Keiser H
    Can J Physiol Pharmacol; 1991 May; 69(5):599-604. PubMed ID: 1650650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.
    Swann PG; Venton DL; Le Breton GC
    FEBS Lett; 1989 Jan; 243(2):244-6. PubMed ID: 2537230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
    Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
    Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
    Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.
    Saussy DL; Mais DE; Knapp DR; Halushka PV
    Circulation; 1985 Dec; 72(6):1202-7. PubMed ID: 2998641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract]   [Full Text] [Related]  

  • 39. Normal response to uraemic platelets to thromboxane A2 agonist.
    Soszka J; Rydzewski A; Myśliwiec M
    Nephron; 1983; 35(4):267-8. PubMed ID: 6680023
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.